Market IntelligenceBreaking
UAE investors chase $39.4 billion GLP-1 opportunity as local healthcare stocks lag
Gulf investors are piling into GLP-1 drug makers Novo Nordisk and Eli Lilly, targeting a $39.4 billion market even as UAE-listed healthcare stocks underperform broader indices by 8-12 percentage points.
7 Apr 2026 · 3 min read
